Clinical Trials on Treatment for Submental Fat in United States

Total 12010 results

Raziel Therapeutics Ltd.

Completed

Efficacy and Safety of RZL-012 on Submental Fat Reduction

Submental Fat

United States
10xBio, LLC

Completed

A Safety and Tolerability Study of 10XB-101 Injections in Adult Subjects With Extra Fat Under the Chin ("Double Chin")

Submental Fat

United States
Raziel Therapeutics Ltd.

Completed

An Open Label Study That Will Test Safety and Efficacy of RZL-012 Injection Into the Submental Fat in Chinese vs. Non-Chinese Subjects.

Submental Fat

United States
Raziel Therapeutics Ltd.

Completed

A Single Blind, Randomized, Placebo-controlled, Phase 2a, 2-cohort Study for the Evaluation of Safety and Efficacy of RZL-012 for Submental Fat Reduction in Healthy Volunteers.

Submental Fat

United States
Raziel Therapeutics Ltd.

Completed

An Open-label Study That Will Test a Second Treatment Session of RZL-012.

Submental Fat

United States
Raziel Therapeutics Ltd.

Completed

Evaluation the Effects of Various Treatments on RZL-012-Induced Adverse Events

Submental Fat

United States
10xBio, LLC

Active, not recruiting

A Safety and Tolerability Study of 10XB-101 Injection in Adult Subjects With Submental Fat

Submental Fat

United States
Rejuven Dermaceutical Co., Ltd.

Completed

RJV001 Study in Adults Receiving Abdominoplasty

Submental Fat (SMF) | Double Chin

United States
Neothetics, Inc

Completed

Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat

Submental Fat

United States
Kythera Biopharmaceuticals

Completed

Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

Healthy | Submental Fat

United States, Canada
Kythera Biopharmaceuticals

Completed

Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

Healthy | Submental Fat

United States, Canada, Australia, United Kingdom
Kythera Biopharmaceuticals

Completed

Patient Experience Study of Deoxycholic Acid Injection

Moderate or Severe Submental Fullness

United States
Kythera Biopharmaceuticals

Completed

Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age

Efficacy | Safety | Moderate to Severe Convexity of Submental Fat

United States
Kythera Biopharmaceuticals

Completed

Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental Fat

Efficacy | Safety | Moderate to Severe Convexity of Submental Fat

United States
Kythera Biopharmaceuticals

Completed

Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study

Moderate or Severe Submental Fullness

United States
Kythera Biopharmaceuticals

Completed

Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area

Moderate or Severe Submental Fullness

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Feasibility Study of Cone Beam Imaging for Radiation Therapy Treatment Verification

Radiation Treatment for Tumors

United States
Kythera Biopharmaceuticals

Completed

Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

Moderate or Severe Submental Fullness

Australia, Canada, United Kingdom
Kythera Biopharmaceuticals

Completed

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area (REFINE-1)

Moderate or Severe Submental Fullness

United States, Canada
Kythera Biopharmaceuticals

Completed

Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat (ATX-101)

Moderate or Severe Submental Fullness

United Kingdom, Canada, Australia
Kythera Biopharmaceuticals

Completed

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Moderate or Severe Submental Fullness

United States, Canada
Kythera Biopharmaceuticals
Bayer

Completed

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

Moderate or Severe Submental Fullness

Belgium, France, Germany, Italy, Spain, United Kingdom
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fasted Conditions

Treatment for Bipolar I Disorder

United States
Kythera Biopharmaceuticals
Bayer

Completed

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

Moderate or Severe Submental Fullness

Germany, France, Belgium, Spain, United Kingdom
Texas Christian University

Active, not recruiting

Mapping Approaches to Prepare for Implementation Transfer (MAP-IT) (MAP-IT)

Mapping Approaches to Prepare for Implementation Transfer | Treatment Readiness and Induction Program

United States
University of Pittsburgh

Withdrawn

Treatment of Benign Breast Deformities and Post-Segmental Mastectomy Breast Deformities With Autologous Fat Grafting (AFT)

Breast Cancer | Mastectomy, Segmental | Lumpectomy

United States
Cutera Inc.

Completed

Multi-Center Pilot Study of Cutera truSculpt Device

Treatment for Cellulite on the Stomach and Flanks

United States
Amgen

Completed

Registry Study for Talimogene Laherparepvec

Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial

Canada, Spain, United States, Germany, Austria, France, Greece, Hungary, Italy, Korea, Republic of, Poland, Russian Federation, South Africa, Switzerland, United Kingdom
VA Office of Research and Development
Yale University

Completed

Evaluation and Treatment of Substance Abuse in Veterans With PTSD Disability Claims (SBIRT-PTSD)

Attendance at Treatment | PTSD, Substance Use, and Attendance at Treatment

United States
University of Pittsburgh
National Center for Complementary and Integrative Health (NCCIH)

Completed

The Healing Context in CAM: Instrument Development and Initial Validation - Calibration Study (HEAL2)

Persons Receiving Any Medical or Behavioral Treatment (Focus of Study is Questionnaires)

United States
Imperial College London

Completed

Predictive Model of Therapy Outcomes in Breast Cancer Patients

Toxicity From Medication (Endocrine Treatment and Chemotherapy) Given for Breast Cancer Treatment.

United Kingdom
Northwestern University

Recruiting

Surgical Approach to Uterine Septum

Treatment Side Effects | Treatment | Surgical Complication | Uterine Septum | Septum; Uterus

United States
UCB Pharma

Completed

Named Patient Program With Rotigotine Transdermal System

Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine

United States
University of Vermont Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Incentive-based Smoking Cessation for Methadone Patients

Cigarette Smoking Among Patients Currently Receiving Methadone or Buprenorphine Treatment for Opioid Dependence

United States
Pop Test Oncology LLC
Baylor College of Medicine; Michael E. DeBakey VA Medical Center; Congressionally... and other collaborators

Completed

Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517) (PT150 PK Study)

Potential Treatment for Alcohol Dependence-Alcohol Interaction

United States
University of Michigan

Recruiting

Digital Design for Maxillofacial Prosthetics

Maxillofacial Abnormalities | Craniofacial Abnormalities | Prosthetic Treatment

United States
University of Florida
National Institute on Aging (NIA)

Enrolling by invitation

Synergizing Home Health Rehabilitation Therapy

Frailty | Rehabilitation | Frail Elderly | Activities of Daily Living | Functional Status | Occupational Therapy | Physical Functional Performance | Treatment Outcome | Health Services for the Aged | Home Health Care

United States
University of Southern California

Completed

Otteroo Case Series

Infants With or at Risk/Concern for Developmental Delay

United States
National Development and Research Institutes, Inc.
Treatment Alternatives for Safe Communities

Unknown

Facilitating MAT Acceptance & Implementation in Problem Solving & Felony Courts

Improving Treatment for Opioid Use Disorder in Courts

United States
Albert Einstein College of Medicine

Recruiting

Primary Radiotherapy for the Treatment of Keloids: A Pilot Study

Safety and Efficacy of Radiation Therapy for the Treatment of Keloids

United States
Lombard Medical

Withdrawn

Evaluation of EndoRefix Endovascular Delivery System and Staple (EndoRefix)

AAA Graft Implant for Primary Aneurysm Treatment | AAA Graft Repair to Extend Life of Implant

United States
Brainsway

Unknown

Combining H1-Coil Deep Transcranial Magnetic Stimulation (dTMS) and App-guided CBT in Subjects With Major Depression Disorder (MDD)

Data Collection for Facilitation of Machine Learning Algorithm for Personalized Treatment

United States
Rutgers, The State University of New Jersey
Monell Chemical Senses Center

Completed

Ibuprofen Inhibits Human Sweet Taste

Treatment of Sweet Taste Receptors Without or With an Oral Rinse of Ibuprofen Solution in Healthy Participants | Treatment of Sweet Taste Receptors Without or With an Oral Rinse of Naproxen Solution in Healthy Participants

United States
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA); University of California, Los Angeles and other collaborators

Completed

CPT for Offenders With SUD (CPT)

Computer-assisted, Evidence-based Psychosocial Intervention | for Substance Abuse Treatment

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Healing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic Leukemia

Leukemia | Fatigue | Psychosocial Effects of Cancer and Its Treatment

United States
River 3 Renal Corp.

Recruiting

Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis

Focal Segmental Glomerulosclerosis | Alport Syndrome

United States, Belgium, United Kingdom, France, Germany, Netherlands
Manchester University NHS Foundation Trust

Completed

Web-based Adherence Information Integrated Nurse-led Monitoring Clinic (WAIN-MC)

Growth Hormone Treatment | Short Stature

United Kingdom
Duke University

Completed

Utility of Postoperative Bracing

Postoperative Bracing for Spinal Deformity

United States
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Individualized Exercise Programs for Patients Receiving Chemotherapy for Newly Diagnosed Acute or Relapsed Myeloid Leukemia or Lymphoblastic Leukemia

Depression | Leukemia | Fatigue | Psychosocial Effects of Cancer and Its Treatment | Musculoskeletal Complications

United States
Amgen

Completed

A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.

Treatment for Prevention of Chronic Migraine

United States, United Kingdom, Poland, Germany, Czechia, Sweden, Canada, Denmark, Finland, Norway

Clinical Trials on Treatment for Submental Fat in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations